OptimizeRx Corp — Director's Dealing 2021

Jun 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-06-30

Reporting Person: Vos Ellen O'Connor (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-30	Common Stock	A	407	—	Acquired	32890	Direct

Footnotes

F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.